Orphanet: A Comprehensive Resource for Rare Disease Knowledge
Navigating the complexities of rare diseases can be a daunting task for patients, caregivers, and healthcare providers. Orphanet serves as a critical online database dedicated to gathering, providing, and improving knowledge on rare diseases. Its primary mission is to enhance the diagnosis, care, and treatment of patients by making rare conditions more visible within global health and research information systems.
To ensure consistency across medical records and research, Orphanet maintains a standard nomenclature known as ORPHAcodes. This standardized coding system helps unify how rare diseases are identified worldwide. To maximize accessibility, the platform is available in nine languages: English, French, German, Dutch, Spanish, Italian, Portuguese, Polish, and Czech. Notably, the website remains entirely free of advertising.
[ไม่มีภาพประกอบ]
Key Facts
- Definition: Rare diseases are defined as those affecting fewer than 1 person per 2,000 (based on European data).
- Standardization: Uses ORPHAcodes to provide a universal nomenclature for rare conditions.
- Scope: Covers disease directories, diagnostic tests, expert centres, orphan drugs, and clinical trials.
- Accessibility: Available in nine languages and contains no advertising.
- Collaboration: Partners with the WHO's International Clinical Trials Registry Platform (ICTRP) to improve trial visibility.
Comprehensive Rare Disease Directories
Disease Search and Identification
Users can search for rare diseases using several parameters. Beyond simple name searches (such as searching for "progeria"), the database allows for precise identification via ICD codes (International Classification of Diseases), OMIM codes (Online Mendelian Inheritance in Man), or the specific name of the associated gene. These searches provide critical data on disease definitions and prevalence.
Diagnostic Tests and Facilities
Orphanet provides a detailed directory of diagnostic tests required to establish a rare disease diagnosis, along with the laboratories capable of performing them. While focused on rare conditions, the directory also includes constitutional genetic tests for non-rare diseases, pharmacogenetics, and diseases with genetic susceptibility. Users can filter these searches by technique, objective, purpose, specialty, or country.
Professional and Institutional Support
Expert Centres and Professionals
Finding specialized care is streamlined through the expert centre directory. Users can locate centres of expertise or networks dedicated to medical management and genetic counselling. These results can be filtered by geography, specificity, and whether the clinic serves adults or pediatric patients.
Additionally, the professional directory lists consultants, physicians, biologists, researchers, and clinical trial investigators who have agreed to be listed, providing a direct link between patients and specialists.
Institutions and Patient Organisations
The platform lists various institutions, including research laboratories, biobanks, and registries. It also features a directory of patient organisations and alliances. To be listed, these organisations must be active, hold legal status, and provide genuine support to patients, though Orphanet does not assume responsibility for the fulfillment of these requirements.
[ไม่มีภาพประกอบ]
Therapeutics and Research
Orphan Drugs
The orphan drug directory tracks substances used to treat rare diseases at all stages of development. This includes drugs granted orphan designation in the USA or Europe, as well as non-designated drugs that have received marketing authorisation for a specific rare disease indication.
Research Projects and Clinical Trials
Orphanet tracks both ongoing and unpublished research projects funded by national bodies or competitive scientific committees. Furthermore, it lists interventional clinical trials aimed at evaluating new treatments. Since 2018, a collaboration with the World Health Organization's International Clinical Trials Registry Platform (ICTRP) has made these trials more identifiable and findable.
Publications and Academic Resources
Orphanet produces regular reports on topics relevant to rare diseases, including a comprehensive annual Activity Report available as a PDF. For academic depth, the Orphanet Journal of Rare Diseases is published in cooperation with Springer Nature, offering free online access to numerous reports and features.
| Category | Primary Purpose | Key Search Parameters |
|---|---|---|
| Disease Directory | Prevalence and definitions | Name, ICD code, OMIM code, Gene |
| Diagnostic Tests | Locating testing laboratories | Country, Technique, Specialty |
| Expert Centres | Medical management & counselling | Geography, Adult/Pediatric, Specificity |
| Orphan Drugs | Treatment tracking | Orphan designation, Marketing authorisation |
| Clinical Trials | Evaluating new therapies | Phase, Recruitment status, Disease |
Frequently Asked Questions
What is a rare disease according to Orphanet?
Based on data from Europe, a rare disease is defined as a condition that affects fewer than 1 person per 2,000.
What are ORPHAcodes?
ORPHAcodes are a standard nomenclature developed by Orphanet to ensure rare diseases are consistently identified and visible across health and research information systems.
How can I find a specialist for a rare condition?
You can use the professional and expert centre directories to find designated medical management centres, genetic counsellors, and physicians who have agreed to be listed on the platform.
Does Orphanet list drugs that aren't officially "orphan drugs"?
Yes. In addition to drugs with official orphan designations in the USA or Europe, Orphanet includes any drug that has been granted marketing authorisation for a specific rare disease indication.
Is the Orphanet Journal of Rare Diseases free to access?
Yes, the journal is published in cooperation with Springer Nature and its reports and features are available online free of charge.